Brez internetne povezave — prikazana je shranjena različica strani.

bioAffinity Techn…

USUSD
← Na Filter Delnic

bioAffinity Technologies, Inc. (US:BIAF) — Biotechnology: Commercial Physical & Biological Resarch. Število borz, na katerih se trgujejo delnice družbe: 1. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O Podjetju

Spletna Stran
bioaffinitytech.com
Odnosi z Vlagatelji
bioaffinitytech.com/contact/
Sektor
Health Care · Biotechnology: Commercial Physical & Biological Resarch
Sedež
SAN ANTONIO, United States
Izvršni Direktor
Maria Zannes
Zaposleni
57
Delnice v Obtoku
8.1 mio. na dan 2026-08-03
Prosto Prenosljive Delnice
532 257
Tržna Kapitalizacija
3.69 mio. USD
Notranje Osebe
0.82%
Institucionalni Vlagatelji
5.62%
Panoga (SIC)
Services-Commercial Physical & Biological Research
P/E
izguba
FCF
−11.6 mio. USD
Dolg
36.5 tis. USD
neto denar
Dobiček in FCF — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
NAV
0.56 USD · P/NAV 6.43
Datum Bilance Stanja30.06.2026
Sredstva7.62 mio. USD
− Obveznosti3.85 mio. USD
= NAV (lastniški delež delničarjev podjetja)3.77 mio. USD
− Dobro Ime1.40 mio. USD
− Neopredmetna Sredstva688 tis. USD
= Opredmetena NAV1.68 mio. USD
Delnice6 783 061
NAV na Delnico0.56 USD
Otipljiv NAV na Delnico0.25 USD
Cena Delnice (BIAF)3.5700 USD
P/NAV6.43
Zgodovina NAV
Datum Bilance StanjaNAVNAV na Delnico
30.06.20263.77 mio. USD0.56 USD
31.03.20263.65 mio. USD0.81 USD
31.12.20257.28 mio. USD1.62 USD
30.09.20258.90 mio. USD2.57 USD
30.06.2025−2.14 mio. USD−0.08 USD
31.03.20251.44 mio. USD0.08 USD
31.12.20242.60 mio. USD5.01 USD
30.09.20243.12 mio. USD0.23 USD
Opis

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
US USA StocksBIAFUSD3.57 -2.46%navadne delnice

Cena v 3 Mesecih

US:BIAF · USD
dan rasti dan padcaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Novice Ta Teden

Sporočila za javnost s spletne strani za vlagatelje podjetja, ki se dnevno posodabljajo. Povezave vodijo na spletno stran podjetja. Naslovi so v izvirnem jeziku, kot na spletni strani podjetja.

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
ZANNES MARIA (Chief Exec…≈46.94%280 3592025-01-10
EDWARDS JAMES MICHAEL CP…≈20.11%120 1282025-01-10
ZANNES TIMOTHY PETER (Ge…≈9.17%54 7652025-01-10
REVELES XAVIER TRINIDAD…≈7.02%41 9432025-01-10
Sabby Management, LLC4.06%24 3772026-06-30
Blackrock Inc.1.1%6 5852026-06-30
Vanguard Capital Managem…0.62%3 7032026-06-30
VANGUARD INDEX FUNDS-Van…0.62%3 7032026-06-30
Geode Capital Management…0.57%3 3982026-06-30
J. Safra Sarasin Holding…0.47%2 8402026-06-30
Vanguard Fiduciary Trust…0.34%2 0712026-06-30
Susquehanna Internationa…0.3%1 7912026-06-30
Jane Street Group, LLC0.3%1 7862026-06-30
Fidelity Concord Street…0.28%1 6592026-07-31
State Street Corporation0.27%1 6062026-06-30
HRT Financial LP0.23%1 3892026-06-30
Fidelity Concord Street…0.08%5092026-07-31
Fidelity Concord Street…0.07%4342026-07-31
Fidelity Concord Street…0.03%1672026-07-31
GIRGENTI STEVEN (Officer…—1.09 mio.2025-01-10